Top 10 Transactions in Q3:17
Ten of the largest deals announced in the third quarter broke the $1.0 billion mark, for a total of $29.9 billion (70% of the quarter’s total spending of $42.7 billion). The largest transaction, Gilead Sciences’ $11.9 billion acquisition of biotech firm Kite Pharma, made up 28% of the quarter’s combined total spending. KKR & Co. made three of these billion-dollar acquisitions, either directly or through portfolio companies, for a total of nearly $7.3 billion. All three targets were publicly traded companies in very discrete fields: internet healthcare source WebMD, air ambulance company American Medical Response, and the... Read More »Health Care M+A Weekly Deals, The Week Ending October 13, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price The Halifax Group Delphi Behavioral Health Group, LLC N/A Lee Equity and FFL Partners Summit Behavioral Healthcare LLC N/A Biotechnology ... Read More »
Stat of the Week: Q3:17 Deal Volume Down 10%
As third quarters go in the cycle of healthcare mergers and acquisitions, big news is not expected. First quarter results may be exciting if the previous year’s fourth quarter was so hectic that a number of deals were pushed into the next year. Second quarters are usually a pause for breath as more books begin to circulate, indicating sellers’ interest in closing a deal by the end of the year. Third quarters tend to stay quiet, or even go dormant. Holidays and vacations are blamed, but for many deal makers, it’s a time to study and gird for the fourth quarter, when regulatory and tax deadlines sometimes loom. Preliminary results for Q3:17 show it is following the typical pattern. With 334... Read More »
Third Quarter Long-Term Care M&A Results Are In
We will be addressing the quarterly seniors housing and healthcare M&A results in Health Care M&A Quarterly Report, which covers all 13 health care sectors. But, here is a preview: Although it remained above 70 deals for the quarter, seniors housing and care M&A activity fell to a year-low, tying with last year’s third quarter at 71 publicly announced transactions. Dollar volume also fell from its recent peak of $9.7 billion in the second quarter of 2017, recording $2.5 billion in transaction value based on disclosed prices. Increasingly, we have seen buyers prefer the one-off deals that come with one or two properties. Those deals are easier to complete and are most... Read More »Health Care M+A Weekly Deals, The Week Ending October 6, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price D’Amore Healthcare, Inc. Pat Moore Foundation N/A Biotechnology Acquirer Target Price Gesynta Pharma AB Rights to OX-MPI program N/A BlueRock... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
